Hedge fund profile
Deep Track Biotechnology Master Fund, Ltd.
Deep Track Biotechnology Master Fund, Ltd. is reported as a hedge fund in Form ADV private-fund disclosures. The adviser is Deep Track Capital, LP, based in Greenwich, Connecticut, United States.
$8.1Bgross assets
$5.0Mminimum
146owners
3(c)(7)exemption
Disclosure fields
Fund facts
SEC private fund ID805-8843084347
Reference ID269385
JurisdictionCayman Islands
Fund of fundsNo
Master fundYes
Feeder fundNo
Non-US ownership16%
Assets valued93%
Annual auditYes
GAAPYes
Source periodMarch 2026
Date submitted03/31/2026 11:47:07 AM
Adviser
TypeRegistered investment adviser
SEC number801-120500
CRD312459
Regulatory AUM$8.4B
Compliance signals
Registration exemption not marked Sales limitation not marked Prime brokers reported Custodians reported
Service providers
Reported counterparties
General partners
Matt Auriemma (director)Julie O'hara (director)David Kroin (director)
Auditors
ERNST & YOUNG LLPERNST & YOUNG LTD.
Prime brokers
UBS SECURITIES LLCJ.P. MORGAN PRIME INC.MORGAN STANLEY & CO. LLC
Custodians
J.P. MORGAN PRIME INC.NORTHERN TRUSTMORGAN STANLEY & CO. LLCUBS SECURITIES LLC
Administrators
MORGAN STANLEY FUND SERVICES USA LLCMORGAN STANLEY FUND SERVICES (CAYMAN) LTD.
Same adviser